Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PRKDC | P78527 | 4/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.36 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | PMM2 | O15305 | 1/20 | 0.32 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12175611 | 0.89 | ALOX5 (0.60) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL14924595 | 0.89 | ALOX5 (0.60) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL16561793 | 0.89 | ALOX5 (0.36) | ALOX5MAOBALDH1A1MAOAKDM4E | |
| SCHEMBL25118636 | 0.88 | ALOX5 (0.58) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL25118644 | 0.88 | ALOX5 (0.58) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL18960985 | 0.88 | ALOX5 (0.50) | ALOX5PRKDCPARP14PIK3CDBRD4 | |
| SCHEMBL16303791 | 0.85 | ALOX5 (0.56) | ALOX5PRKDCPARP14SLC9A1PIK3CD | |
| SCHEMBL30393630 | 0.85 | ALOX5 (0.56) | ALOX5PRKDCPARP14SLC9A1PIK3CD | |
| SCHEMBL24257894 | 0.85 | ALOX5 (0.56) | ALOX5PRKDCPARP14SLC9A1PIK3CD | |
| SCHEMBL18961003 | 0.85 | ALOX5 (0.56) | ALOX5PRKDCPARP14SLC9A1PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10804469-B2 | Charge transport material, organic electroluminescent element, and illumination device, display device, or light-emitting device characterized by using said element | UDC IRELAND LIMITED (IE) | 2020-10-13 | — | — | US | disclosed |
| US-20150069332-A1 | CHARGE TRANSPORT MATERIAL, OGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE, DISPLAY DEVICE, OR LIGHT-EMITTING DEVICE CHARACTERIZED BY USING SAID ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-12 | — | — | US | disclosed |
| US-20150069332-A1 | CHARGE TRANSPORT MATERIAL, OGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE, DISPLAY DEVICE, OR LIGHT-EMITTING DEVICE CHARACTERIZED BY USING SAID ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10804469-B2 | Charge transport material, organic electroluminescent element, and illumination device, display device, or light-emitting device characterized by using said element | ITGAL, ITGA1, ITGB1 | ALOX5 4247/4885PRKDC 4222/4885PARP14 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.